These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke. Sarmah D; Datta A; Kaur H; Kalia K; Borah A; Rodriguez AM; Yavagal DR; Bhattacharya P Stem Cell Rev Rep; 2022 Feb; 18(2):821-838. PubMed ID: 35112234 [TBL] [Abstract][Full Text] [Related]
4. Intra-arterial stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke. Saraf J; Sarmah D; Vats K; Kaur H; Pravalika K; Wanve M; Kalia K; Borah A; Dave KR; Yavagal DR; Bhattacharya P Int J Neurosci; 2019 Oct; 129(10):1039-1044. PubMed ID: 31203689 [No Abstract] [Full Text] [Related]
5. Post-stroke Impairment of the Blood-Brain Barrier and Perifocal Vasogenic Edema Is Alleviated by Endovascular Mesenchymal Stem Cell Administration: Modulation of the PKCδ/MMP9/AQP4-Mediated Pathway. Datta A; Sarmah D; Kaur H; Chaudhary A; Mounica KL; Kalia K; Borah A; Yavagal DR; Bhattacharya P Mol Neurobiol; 2022 May; 59(5):2758-2775. PubMed ID: 35187613 [TBL] [Abstract][Full Text] [Related]
6. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats. Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779 [TBL] [Abstract][Full Text] [Related]
7. Intra-arterial Stem Cell Therapy Diminishes Inflammasome Activation After Ischemic Stroke: a Possible Role of Acid Sensing Ion Channel 1a. Vats K; Sarmah D; Datta A; Saraf J; Kaur H; Pravalika K; Wanve M; Kalia K; Borah A; Dave KR; Yavagal DR; Bhattacharya P J Mol Neurosci; 2021 Feb; 71(2):419-426. PubMed ID: 31820348 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model. Jeong CH; Kim SM; Lim JY; Ryu CH; Jun JA; Jeun SS Biomed Res Int; 2014; 2014():129145. PubMed ID: 24672780 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. Yavagal DR; Lin B; Raval AP; Garza PS; Dong C; Zhao W; Rangel EB; McNiece I; Rundek T; Sacco RL; Perez-Pinzon M; Hare JM PLoS One; 2014; 9(5):e93735. PubMed ID: 24807059 [TBL] [Abstract][Full Text] [Related]
10. Human UCB-MSCs treatment upon intraventricular hemorrhage contributes to attenuate hippocampal neuron loss and circuit damage through BDNF-CREB signaling. Ko HR; Ahn SY; Chang YS; Hwang I; Yun T; Sung DK; Sung SI; Park WS; Ahn JY Stem Cell Res Ther; 2018 Nov; 9(1):326. PubMed ID: 30463591 [TBL] [Abstract][Full Text] [Related]
11. Early Transplantation of Human Cranial Bone-derived Mesenchymal Stem Cells Enhances Functional Recovery in Ischemic Stroke Model Rats. Oshita J; Okazaki T; Mitsuhara T; Imura T; Nakagawa K; Otsuka T; Kurose T; Tamura T; Abiko M; Takeda M; Kawahara Y; Yuge L; Kurisu K Neurol Med Chir (Tokyo); 2020 Feb; 60(2):83-93. PubMed ID: 31956170 [TBL] [Abstract][Full Text] [Related]
12. Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke. Huang W; Mo X; Qin C; Zheng J; Liang Z; Zhang C Neurol Res; 2013 Apr; 35(3):320-8. PubMed ID: 23485057 [TBL] [Abstract][Full Text] [Related]
13. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke. Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic efficacy of lentiviral vector mediated BDNF gene-modified MSCs in cerebral infarction]. Huang D; Zhang Z; Chen B; Wu X; Wang N; Zhang Y Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1174-9. PubMed ID: 18837391 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of a Combination of Electroacupuncture and TrkB-Expressing Mesenchymal Stem Cells for Ischemic Stroke. Ahn SM; Kim YR; Shin YI; Ha KT; Lee SY; Shin HK; Choi BT Mol Neurobiol; 2019 Jan; 56(1):157-173. PubMed ID: 29682700 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor (BDNF) tohuman umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) promotescrush-injured rat sciatic nerve regeneration. Hei WH; Almansoori AA; Sung MA; Ju KW; Seo N; Lee SH; Kim BJ; Kim SM; Jahng JW; He H; Lee JH Neurosci Lett; 2017 Mar; 643():111-120. PubMed ID: 28215880 [TBL] [Abstract][Full Text] [Related]
18. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757 [TBL] [Abstract][Full Text] [Related]
19. Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery. Nam HS; Kwon I; Lee BH; Kim H; Kim J; An S; Lee OH; Lee PH; Kim HO; Namgoong H; Kim YD; Heo JH PLoS One; 2015; 10(12):e0144218. PubMed ID: 26637168 [TBL] [Abstract][Full Text] [Related]
20. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats. Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]